FDA Inspection
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries – FDA Inspection, Jun 22, 2015
Record Details
This FDA Inspection record concerns Teva Pharmaceutical Industries, with an inspection on June 22, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 22, 2015
- Product Type
- Drugs
View Company Profile
ID · 038e4bb1-ab1f-4afc-be97-efa2282303d6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 935714
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.80(a)Procedures To Be in Writing
- 21 CFR 211.110(a)Written in-process control procedures
- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Teva Pharmaceutical Industries
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 16, 2010 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Pharmaceutical Industries
- FDA Inspection 1101325 - 2019-08-01
- FDA Inspection 733882 - 2011-06-19
- FDA Inspection 695835 - 2010-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.